SyntekaBio, Inc. (KOSDAQ: 226330)
South Korea
· Delayed Price · Currency is KRW
5,690.00
+10.00 (0.18%)
Nov 18, 2024, 2:29 PM KST
SyntekaBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 19,746 | 19,668 | 35,342 | 13,709 | 2,651 |
Short-Term Investments | - | - | - | 39,000 | 38,440 |
Cash & Short-Term Investments | 19,746 | 19,668 | 35,342 | 52,709 | 41,091 |
Cash Growth | -34.86% | -44.35% | -32.95% | 28.27% | - |
Accounts Receivable | 32.54 | 0.25 | 1.07 | 55.04 | 22.62 |
Other Receivables | 16.3 | 40.67 | 132.56 | 113.44 | 251.14 |
Receivables | 48.84 | 40.91 | 133.63 | 168.48 | 273.76 |
Prepaid Expenses | 172.29 | 374.72 | 351.44 | 185.38 | 62.07 |
Other Current Assets | 880.09 | 1,896 | 1,670 | 5,131 | 110.05 |
Total Current Assets | 20,847 | 21,980 | 37,497 | 58,193 | 41,536 |
Property, Plant & Equipment | 31,722 | 30,461 | 17,475 | 9,054 | 2,582 |
Other Intangible Assets | 433.26 | 443.85 | 631.99 | 432.98 | 475.02 |
Long-Term Accounts Receivable | -0 | 0 | 0 | -0 | -0 |
Other Long-Term Assets | 28.03 | 31.88 | 85.2 | 198.27 | 184.65 |
Total Assets | 53,030 | 52,917 | 55,689 | 67,879 | 44,778 |
Accrued Expenses | 347.08 | 357.38 | 249.06 | 226.04 | 280.21 |
Short-Term Debt | 6,892 | 1,803 | 10,454 | - | - |
Current Portion of Leases | 129.08 | 262.66 | 415.2 | 198.59 | 470.96 |
Other Current Liabilities | 11,602 | 16,975 | 11,136 | 1,464 | 286.2 |
Total Current Liabilities | 18,970 | 19,398 | 22,254 | 1,888 | 1,037 |
Long-Term Debt | - | - | - | 8,152 | - |
Long-Term Leases | 1.83 | 27.94 | 251.65 | 485.11 | 552.24 |
Other Long-Term Liabilities | 207.47 | 191.29 | 152.09 | 28,389 | 161.12 |
Total Liabilities | 21,399 | 21,688 | 24,228 | 40,252 | 3,238 |
Common Stock | 7,629 | 7,615 | 6,759 | 6,750 | 6,681 |
Additional Paid-In Capital | 92,989 | 92,602 | 80,933 | 73,428 | 71,986 |
Retained Earnings | -69,315 | -69,018 | -57,452 | -53,051 | -38,363 |
Comprehensive Income & Other | 327.07 | 29.3 | 1,221 | 500.14 | 1,236 |
Shareholders' Equity | 31,631 | 31,228 | 31,461 | 27,627 | 41,540 |
Total Liabilities & Equity | 53,030 | 52,917 | 55,689 | 67,879 | 44,778 |
Total Debt | 7,023 | 2,094 | 11,121 | 8,836 | 1,023 |
Net Cash (Debt) | 12,723 | 17,574 | 24,222 | 43,873 | 40,067 |
Net Cash Growth | -42.31% | -27.45% | -44.79% | 9.50% | - |
Net Cash Per Share | 838.14 | 1227.54 | 1792.34 | 3258.50 | 3024.90 |
Filing Date Shares Outstanding | 15.26 | 15.23 | 13.52 | 13.5 | 13.36 |
Total Common Shares Outstanding | 15.26 | 15.23 | 13.52 | 13.5 | 13.36 |
Working Capital | 1,877 | 2,581 | 15,242 | 56,305 | 40,499 |
Book Value Per Share | 2073.02 | 2050.38 | 2327.37 | 2046.46 | 3108.82 |
Tangible Book Value | 31,198 | 30,784 | 30,829 | 27,194 | 41,065 |
Tangible Book Value Per Share | 2044.63 | 2021.24 | 2280.62 | 2014.38 | 3073.27 |
Land | 4,954 | 4,954 | 4,936 | 4,936 | - |
Buildings | 22,355 | 22,335 | - | - | - |
Machinery | 9,866 | 7,562 | 6,144 | 5,654 | 3,439 |
Construction In Progress | - | - | 9,212 | 208 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.